|
THE SIMPLE FACTSTM...Raptiva (efalizumab) is a drug that was developed by Genentech for treating psoriasis and was approved by the U.S. Food and Administration (FDA) in 2003.
Unfortunately, Raptiva has been associated with a possible side effect/injury, progressive multifocal leukoencephalopathy (PML) (and death), a rare and usually fatal disease of the central nervous system and brain. Around 80 percent of those who develop PML die within six months. PML causes serious neurological problems for those who survive the disease.
According to many reports, the recalled/withdrawn drug Raptiva may have a number of serious side effects, including:
- Chills or fever
- Headache
- Nausea
- Flu like symptoms
- Sore Throat
According to the FDA, the drug Raptiva will no longer be available (recall/withdrawn) in the United States after June 8, 2009.
If you are taking Raptiva and developed an injury/side effect, or know someone who is, please speak to a doctor immediately.
For more information on the recalled/withdrawn drug Raptiva and the possible side effects or injury, click here.
Quite frankly, the simple factsTM about the recalled/withdrawn Genentech drug Raptiva and the possible injuries (PML and possible death), side effects or other health complications that may be caused by taking Raptiva are unacceptable.
We are investigating claims of progressive multifocal leukoencephalopathy (PML) or injuries in connection with possible side effects and problems from the use of the drug Raptiva.
We are here to help you protect your legal rights and the legal rights of your loved ones.
|
